Amazon Gets Into Boner Pill Business, Hims Stock Goes Limp

Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new service Thursday that offers upfront pricing for telehealth visits for a range of issues and ailments — including men’s hair loss,
What's Going On With Hims & Hers Health Stock On Wednesday?
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing rising demand and pharmacy shortages.
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
The pricing will show up at checkout when users are logged into Amazon with a Prime membership. Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...
Becker's Hospital Review5h
Hims & Hers launches GLP-1 tracker amid shortages
Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
Hims & Hers launching GLP-1 tracker, Yahoo Finance reports
In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers once again delivered a blowout quarter with surging revenue. Revenue soared 77% year over year to $401.6 million, ...
Seeking Alpha9d
Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow
HIMS boasts high gross margins (~80%) with no R&D risk, capitalizing on the shift away from traditional pharmacies to ...
Modern Healthcare2d
Hims & Hers, Talkspace among Q3 winners in digital health
Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.
Drug Store News1d
Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Yahoo Finance3d
Hims & Hers' Shares Jump 17%: Explosive Growth, Insider Confidence, and Big Money Moves
Analysts are buzzing as well, with TD Cowen raising its price target to $28, citing HIMS' diverse revenue streams and ...